References
- Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524–15529.
- Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009;136:26–36.
- Mraz M, Pospisilova S, Malinova K, et al. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 2009;50:506–509.
- Basso K, Sumazin P, Morozov P, et al. Identification of the human mature B cell miRNome. Immunity 2009;30:744–752.
- Belver L, de Yébenes VG, Ramiro AR. MicroRNAs prevent the generation of autoreactive antibodies. Immunity 2010;33:713–722.
- Kluiver JL, Chen CZ. MicroRNAs regulate B-cell receptor signaling-induced apoptosis. Genes Immun 2012;13:239–244.
- Li S, Moffett HF, Lu J, et al. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS One 2011;6:e16956.
- Bomben R, Gobessi S, Bo MD, et al. The miR-17-92 family regulates the response to toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia 2012;26:1584–1593.
- Vigorito E, Perks KL, Abreu-Goodger C, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007;27:847–859.
- Vargova K, Curik N, Burda P, et al. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 2011;117:3816–3825.
- Yin Q, Wang X, McBride J, et al. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem 2008;283:2654–2662.
- Gatto G, Rossi A, Rossi D, et al. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 2008;36:6608–6619.
- Chen L, Cui B, Chen G, et al. miR-155 contributed to chronic lymphocytic leukemia survival by modulation of BCR-signalling. Blood 2011;118(Suppl. 1): Abstract 620.
- Zhang Y, Roccaro AM, Rombaoa C, et al. LNA-mediated anti-microRNA-155 silencing in low-grade B cell lymphomas. Blood 2012;120:1678–1686.
- Mraz M, Malinova K, Kotaskova J, et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 2009;23:1159–1163.
- Stamatopoulos B, Meuleman N, Haibe-Kains B, et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009;113:5237–5245.
- Mraz M, Rassenti ZL, Ghia EM, et al. The target genes and prognostic significance of miR-150 in chronic lymphocytic leukemia. Blood 2012;120:(Suppl. 1): Abstract 3859.
- Visone R, Veronese A, Rassenti LZ, et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood 2011;118:3072–3079.
- Sampath D, Liu C, Vasan K, et al. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 2012;119:1162–1172.
- Mraz M, Dolezalova D, Plevova K, et al. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood 2012;119:2110–2113.